Get the Stockscreener App
24.67
0.28%
0.07
After Hours:
24.62
-0.05
-0.20%
Indivior Plc stock is traded at $24.67, with a volume of 2.25M.
It is up +0.28% in the last 24 hours and up +17.20% over the past month.
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.
See More
Previous Close:
$24.60
Open:
$24.58
24h Volume:
2.25M
Relative Volume:
0.88
Market Cap:
$3.03B
Revenue:
$1.12B
Net Income/Loss:
$5.00M
P/E Ratio:
2,467.00
EPS:
0.01
Net Cash Flow:
$-383.00M
1W Performance:
+1.27%
1M Performance:
+17.20%
6M Performance:
+158.32%
1Y Performance:
+102.71%
1-Day Range:
$24.54
$24.97
1-Week Range:
$23.59
$24.97
52-Week Range:
$7.33
$25.00
Indivior Plc Stock (INDV) Company Profile
Name
Indivior Plc
Sector
Phone
804-379-1090
Address
234 BATH ROAD, SLOUGH, BERKSHIRE
Compare INDV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INDV
Indivior Plc
|
24.67 | 3.03B | 1.12B | 5.00M | -383.00M | 0.01 |
|
ZTS
Zoetis Inc
|
152.43 | 69.31B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.15 | 47.34B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.89 | 43.88B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.76 | 21.08B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
391.45 | 13.78B | 2.99B | 1.21B | 1.13B | 25.06 |
Indivior Plc Stock (INDV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-06-25 | Initiated | H.C. Wainwright | Buy |
| Jul-22-25 | Resumed | Jefferies | Buy |
| Jan-28-25 | Initiated | Rodman & Renshaw | Buy |
| Jul-23-24 | Initiated | Piper Sandler | Overweight |
| Apr-03-24 | Initiated | Craig Hallum | Buy |
| Jul-13-23 | Initiated | Northland Capital | Outperform |
View All
Indivior Plc Stock (INDV) Latest News
Indivior Attorney Rejoins McGuireWoods In Virginia - Law360
Real time pattern detection on Indivior PLC stockGlobal Markets & Risk Controlled Daily Plans - Newser
What machine learning models say about Indivior PLCMarket Sentiment Summary & Accurate Buy Signal Alerts - Newser
Using data models to predict Indivior PLC stock movementShort Setup & Advanced Technical Analysis Signals - Newser
Comparing Indivior PLC in custom built stock radarsJuly 2025 Drop Watch & Expert Curated Trade Setup Alerts - Newser
How the Naloxone Market Evolve by 2032Growth, Segments, - openPR.com
Combining machine learning predictions for Indivior PLCWeekly Gains Report & High Accuracy Trade Signal Alerts - Newser
Understanding Indivior PLC’s price movementJuly 2025 Outlook & Fast Entry and Exit Trade Plans - Newser
Should you hold or exit Indivior PLC nowFed Meeting & Reliable Price Breakout Signals - Newser
Indivior PLC stock daily chart insightsWeekly Trade Recap & Free Community Consensus Stock Picks - Newser
Is Indivior PLC meeting your algorithmic filter criteriaJuly 2025 Summary & Daily Stock Momentum Reports - Newser
Will Indivior PLC rebound enough to break evenWeekly Risk Report & Fast Exit Strategy with Risk Control - Newser
Is Indivior PLC building a consolidation baseCPI Data & Accurate Technical Buy Alerts - Newser
Indivior PLC recovery potential after sell offJuly 2025 Momentum & Accurate Technical Buy Alerts - Newser
What earnings revisions data tells us about Indivior PLCQuarterly Trade Review & Reliable Breakout Forecasts - Newser
Indivior Plc (INDV) Jumps 22.8% on Impressive Earnings, Outlook - MSN
Can Indivior PLC expand into new marketsJuly 2025 Outlook & Capital Efficiency Focused Ideas - khodrobank.com
Signal strength of Indivior PLC stock in tech scanners2025 Short Interest & Real-Time Volume Triggers - Newser
What MACD and RSI say about Indivior PLCPortfolio Return Summary & Safe Entry Momentum Tips - Newser
Indivior PLC Inches Toward Key Resistance — Will It Break getLinesFromResByArray error: size == 0 - thegnnews.com
Indivior Launches Action Agenda for Business Enhancement - MSN
What data driven models say about Indivior PLC’s futureDay Trade & AI Powered Market Trend Analysis - Newser
Is Indivior PLC still worth holding after the dipVolume Spike & Community Verified Swing Trade Signals - Newser
Is now a turning point for Indivior PLCJuly 2025 PreEarnings & Scalable Portfolio Growth Ideas - Newser
Indivior PLC stock retracement – recovery analysisQuarterly Profit Summary & High Win Rate Trade Tips - Newser
Why is Indivior PLC stock going upTrade Exit Summary & Safe Capital Preservation Plans - khodrobank.com
What’s the beta of Indivior PLC stockEntry Point & Reliable Intraday Trade Alerts - khodrobank.com
Technical Heatmap Flags Indivior PLC for Watch2025 Earnings Impact & AI Forecasted Stock Moves - beatles.ru
Custom strategy builders for tracking Indivior PLCMarket Trend Report & Real-Time Price Movement Reports - Newser
Indivior price target raised to $34 from $27 at Craig-Hallum - MSN
Published on: 2025-08-31 19:00:28 - Newser
What to expect from Indivior PLC in the next 30 daysTrade Ideas & Fast Moving Market Watchlists - Newser
Predicting Indivior PLC trend using moving averagesJuly 2025 PostEarnings & Detailed Earnings Play Strategies - Newser
Levi & Korsinsky Reminds Indivior Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 1, 2024INDV - ACCESS Newswire
What’s the recovery path for long term holders of Indivior PLCJobs Report & High Return Trade Guides - Newser
What makes Indivior PLC stock price move sharplyWeekly Volume Report & AI Forecast for Swing Trade Picks - Newser
Screener Results Flag Indivior PLC as Oversold getLinesFromResByArray error: size == 0 - newsyoung.net
Indivior Plc Stock (INDV) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.04%
2.80%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):